These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7386234)

  • 1. The antihypertensive effect of prazosin on mild to moderate hypertension, changes in plasma volume, extracellular volume and glomerular filtration rate.
    McNair A; Rasmussen S; Nielsen PE; Rasmussen K
    Acta Med Scand; 1980; 207(5):413-6. PubMed ID: 7386234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in plasma volume and extracellular fluid volume after addition of prazosin to propranolol treatment in patients with hypertension.
    Ibsen H; Rasmussen K; Jensen HA; Leth A
    Scand J Clin Lab Invest; 1978 Sep; 38(5):425-9. PubMed ID: 705227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood pressure, plasma volume, extracellular volume and glomerular filtration rate during treatment with labetalol in essential hypertension.
    Rasmussen S; Nielsen PE
    Postgrad Med J; 1980; 56 Suppl 2():33-6. PubMed ID: 7433340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood pressure, body fluid volumes and glomerular filtration rate during treatment with labetalol in essential hypertension.
    Rasmussen S; Nielsen PE
    Br J Clin Pharmacol; 1981 Sep; 12(3):349-53. PubMed ID: 7295465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of prazosin therapy on BP, renal function, and body fluid composition.
    Bauer JH; Jones LB; Gaddy P
    Arch Intern Med; 1984 Jun; 144(6):1196-200. PubMed ID: 6732379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiologic evaluation of a new antihypertensive agent: prazosin HCl.
    Koshy MC; Mickley D; Bourgiognie J; Blaufox MD
    Circulation; 1977 Mar; 55(3):533-7. PubMed ID: 837488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in plasma volume and extracellular fluid volume and after addition of hydralazine to propranolol treatment in patients with hypertension.
    Ibsen H; Rasmussen K; Jensen HA; Leth A
    Acta Med Scand; 1978; 203(5):419-23. PubMed ID: 665309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal perfusion changes during treatment of essential hypertension: prazosin versus propranolol.
    O'Connor DT; Preston RA; Sasso EH
    J Cardiovasc Pharmacol; 1979; 1(6 Suppl):S38-42. PubMed ID: 94638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal haemodynamic effects of bunazosin retard and prazosin in mild to moderately hypertensive patients with normal or moderately impaired renal function.
    Anderton JL; Gill M; Notghi A
    Nephrol Dial Transplant; 1994; 9(6):607-12. PubMed ID: 7970085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orthostatic hypotension after the first administration of prazosin in hypertensive patients: role of the plasma volume.
    Semplicini A; Pessina AC; Palatini P; Hlede M; Palù CD
    Clin Exp Pharmacol Physiol; 1981 Jan; 8(1):1-10. PubMed ID: 6162595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of metoprolol, alone and in combination with a thiazide diuretic, on blood pressure, plasma volume, extracellular volume and glomerular filtration rate in essential hypertension.
    Rasmussen S; Rasmussen K
    Eur J Clin Pharmacol; 1979 Jun; 15(5):305-10. PubMed ID: 378672
    [No Abstract]   [Full Text] [Related]  

  • 12. Prediction of response to antihypertensive therapy with prazosin.
    MacCarthy EP; Frost GW; Monaghan JC; Mennie BA; Stokes GS
    Med J Aust; 1980 Jul; 2(SP1):12-4. PubMed ID: 7421719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in plasma and extracellular fluid volume during long-term treatment with alpha-methyldopa in 11 thiazide-treated patients with essential hypertension.
    Leth A; Ibsen H
    Acta Med Scand; 1975; 198(1-2):45-8. PubMed ID: 1166823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous measurement of extracellular fluid distribution and renal function with a single injection of 99mTc DTPA.
    Peters AM; Allison H; Ussov WYu
    Nephrol Dial Transplant; 1995 Oct; 10(10):1829-33. PubMed ID: 8592589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular consequences of primary antihypertensive therapy with prazosin hydrochloride.
    Scharf SC; Lee HB; Wexler JP; Blaufox MD
    Am J Cardiol; 1984 Jan; 53(3):32A-36A. PubMed ID: 6364759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of prazosin on plasma renin activity and blood pressure.
    Karlberg BE; Thulin T; Fagerberg SE; Schersten B; Tolagen K; Vikesdal O; Malmberg L
    J Clin Pharmacol; 1979 Jul; 19(7):357-65. PubMed ID: 479380
    [No Abstract]   [Full Text] [Related]  

  • 17. Initial and long-term effects of prazosin on sympathetic vasopressor responses in essential hypertension.
    Khatri IM; Levinson P; Notargiacomo A; Freis ED
    Am J Cardiol; 1985 Apr; 55(8):1015-8. PubMed ID: 3984860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of prazosin as initial antihypertensive therapy.
    Okun R
    Am J Cardiol; 1983 Feb; 51(4):644-50. PubMed ID: 6829427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prazosin: preliminary clinical and pharmacological observations.
    Bolli P; Wood AJ; Phelan EL; Lee DR; Simpson FO
    Clin Sci Mol Med Suppl; 1975 Jun; 2():177s-179s. PubMed ID: 802632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prazosin in hypertension with and without methyldopa.
    Kochar MS; Zeller JR; Itskovitz HD
    Clin Pharmacol Ther; 1979 Feb; 25(2):143-8. PubMed ID: 365428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.